- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03501446
A Pilot Validation Study of Continuous CO2-based End-expiratory Lung Volume Measurements in Humans. (ELVIS)
A Pilot Validation Study of Continuous CO2-based End-expiratory Lung Volume Measurements in Humans and an Experimental Porcine Model.
Study Overview
Status
Conditions
Detailed Description
The capnodynamic method continuously calculates effective lung volume (ELV) with the help of a capnodynamic equation:
ELV x (FACO2(n) - FACO2(n-1)) = delta t(n) x EPBF (CvCO2 - CvCO2(n)) - VTCO2. ELV Effective lung volume [L]. EPBF Effective pulmonary blood flow [L/min]. n current breath. n-1 previous breath. FACO2 mean alveolar carbon dioxide fraction. CvCO2 mixed venous carbon dioxide content [Lgas/Lblood]. CcCO2n pulmonary end-capillary carbon dioxide content [Lgas/Lblood]. VTCO2n volume [L] of carbon dioxide eliminated by the current, nth, breath. delta t n current breath cycle time [min]. The equation above describes the mole balance between the CO2 delivered to lungs (EPBF), the volume taking part in the gas exchange (ELV) and CO2 excreted from the lungs (VTCO2). Normally there is no difference in CO2 between the actual and the preceding breath as the same amount of CO2 as delivered to the lungs as is excreted. When small changes in CO2 concentration are inserted into the equation obtained with short inspiratory pauses in three out of nine breaths, nine different equations are obtained. The three unknown variables; ELV, EPBF and CvCO2 can be solved with a linear least square optimization, a well-known numerical mathematical principle. The breathing pattern is automatically controlled by the ventilator which provides continuous calculations of ELV where each value represents the average of the preceding nine breaths and renews with each breath as the newest replaces the oldest in the equation system.
At the day of surgery, included patients arrive at the surgical unit. After safe surgical checklist, vital signs are measured patients are anesthetized and muscle relaxed per routine practice. An endotracheal tube is inserted in the trachea and the patient connected to a ventilator. Anesthesia is maintained with Propofol in target controlled infusion and a short acting opioid is added as needed.
The protocol comprises a measurement of functional residual capacity (FRC) with the reference method, nitrogen multiple breath wash out (NMBW), at 0 cm H2O Positive End Expiratory Pressure (PEEP). The tracheal tube is then connected to the Servo-i ventilator with the capnodynamic breathing pattern applied. An ELV measurement at PEEP 0 cm H2O is followed by a measurement of ELV at PEEP 10 cm H2O and lastly a measurement of ELV at PEEP 5 cm H2O before the tube is clamped and connected to the NMBW reference method ventilator again for a measurement of FRC at PEEP 5 cm H2O.
The attending anesthesiologist has the final responsibility of the patient and could at any time end the protocol if needed.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Stockholm
-
Solna, Stockholm, Sweden, SE-171 76
- Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Individuals without current heart or lung disease
Exclusion Criteria:
- Obesitas
- Heart disease
- Lung disease
- Current smoker
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effective lung volume
Time Frame: Continous measurements during general anaesthesia and mechanical ventialtion, 45 minutes-2 hours
|
Lung volume measurements during mechanical ventilation based on CO2 dynamics and a differentiated Fick's principle.
|
Continous measurements during general anaesthesia and mechanical ventialtion, 45 minutes-2 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Håkan Björne, PhD, Karolinska Institutet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2014/1393-31/2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Function
-
VA Office of Research and DevelopmentUnited States Department of Defense; Harvard UniversityEnrolling by invitation
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Preventive Services and Health Promotion Research NetworkCompleted
-
University of UtahWithdrawnPulmonary FunctionUnited States
-
Assiut UniversityCompletedPulmonary FunctionEgypt
-
TechnopulmNot yet recruitingPulmonary Function Testing
-
Universitas PadjadjaranCompletedPostoperative Pulmonary Function ImpairmentIndonesia
-
Icahn School of Medicine at Mount SinaiColumbia University; Kintampo Health Research Centre, GhanaCompletedPulmonary Function | Oxidant ImbalanceGhana
-
Medical University of GdanskCompletedHealthy | Pulmonary Function TestPoland
-
Boston Children's HospitalWithdrawnInadequate; Pulmonary Function, Newborn